Erratum: Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach (Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach (2012) 20(10) (1953–1967), (S152500161632192X), (10.1038/mt.2012.117));Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach

Molecular Therapy

Volumn 20, Issue 10, 2012, Pages 1953-1967

  Moschidou, Dafni ^a   Mukherjee, Sayandip ^b   Blundell, Michael P ^b   Drews, Katharina ^c   Jones, Gemma N ^a   Abdulrazzak, Hassan ^a   Nowakowska, Beata ^d   Phoolchund, Anju ^a   Lay, Kenneth ^a   Ramasamy, T Selvee ^a   Cananzi, Mara ^b   Nettersheim, Daniel ^e   Sullivan, Mark ^a   Frost, Jennifer ^b   Moore, Gudrun ^b   Vermeesch, Joris R ^d   Fisk, Nicholas M ^f   Thrasher, Adrian J ^b   Atala, Anthony ^g   Adjaye, James ^c,h   Schorle, Hubert ^e   De Coppi, Paolo ^b   Guillot, Pascale V ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR; TELOMERASE; TRANSCRIPTOME; VALPROIC ACID;

ADIPOCYTE; AMNIOTIC FLUID STEM CELL; ARTICLE; BONE CELL; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDODERM; ENZYME ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; NERVE CELL; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; TERATOMA; TRANSGENE; X CHROMOSOME INACTIVATION;

EID: 84866994859     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1016/j.ymthe.2024.06.015     Document Type: Erratum

References (49)

1. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126: 663-676.
2. Mukherjee, S and Thrasher, AJ (2011). iPSCs: Unstable origins? Mol Ther 19: 1188-1190.
3. Li, C, Zhou, J, Shi, G, Ma, Y, Yang, Y, Gu, J et al. (2009). Pluripotency can be rapidly and effciently induced in human amniotic fuid-derived cells. Hum Mol Genet 18: 4340-4349.
4. Fusaki, N, Ban, H, Nishiyama, A, Saeki, K and Hasegawa, M (2009). Effcient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad, Ser B, Phys Biol Sci 85: 348-362.
5. Hu, K, Yu, J, Suknuntha, K, Tian, S, Montgomery, K, Choi, KD et al. (2011). Effcient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117: e109-e119.
6. Narsinh, KH, Jia, F, Robbins, RC, Kay, MA, Longaker, MT and Wu, JC (2011). Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 6: 78-88.
7. Kaji, K, Norrby, K, Paca, A, Mileikovsky, M, Mohseni, P and Woltjen, K (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
8. Warren, L, Manos, PD, Ahfeldt, T, Loh, YH, Li, H, Lau, F et al. (2010). Highly effcient reprogramming to pluripotency and directed differentiation of human cells with synthetic modifed mRNA. Cell Stem Cell 7: 618-630.
9. Kim, D, Kim, CH, Moon, JI, Chung, YG, Chang, MY, Han, BS et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
10. Okita, K, Matsumura, Y, Sato, Y, Okada, A, Morizane, A, Okamoto, S et al. (2011). A more effcient method to generate integration-free human iPS cells. Nat Methods 8: 409-412.
11. Galende, E, Karakikes, I, Edelmann, L, Desnick, RJ, Kerenyi, T, Khoueiry, G et al. (2010). Amniotic fuid cells are more effciently reprogrammed to pluripotency than adult cells. Cell Reprogram 12: 117-125.
12. Zhou, H, Li, W, Zhu, S, Joo, JY, Do, JT, Xiong, W et al. (2010). Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J Biol Chem 285: 29676-29680.
13. Di Stefano, B, Prigione, A and Broccoli, V (2009). Effcient genetic reprogramming of unmodifed somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4. Stem Cells Dev 18: 707-716.
14. Kim, JB, Sebastiano, V, Wu, G, Araúzo-Bravo, MJ, Sasse, P, Gentile, L et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411-419.
15. Sterneckert, J, Höing, S and Schöler, HR (2012). Concise review: Oct4 and more: the reprogramming expressway. Stem Cells 30: 15-21.
16. Kaviani, A, Guleserian, K, Perry, TE, Jennings, RW, Ziegler, MM and Fauza, DO (2003). Fetal tissue engineering from amniotic fuid. J Am Coll Surg 196: 592-597.
17. Tsai, MS, Lee, JL, Chang, YJ and Hwang, SM (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fuid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456.
18. De Coppi, P, Bartsch, G Jr, Siddiqui, MM, Xu, T, Santos, CC, Perin, L et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
19. Ryan, JM, Pettit, AR, Guillot, PV, Chan, JK and Fisk, NM (2011). Unravelling the Pluripotency Paradox in Fetal and Placental Mesenchymal Stem Cells: Oct-4 Expression and the Case of the Emperor's New Clothes. Stem Cell Rev (epub ahead of print).
20. Huangfu, D, Osafune, K, Maehr, R, Guo, W, Eijkelenboom, A, Chen, S et al. (2008). Induction of pluripotent stem cells from primary human fbroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
21. Chen, YS, Pelekanos, RA, Ellis, RL, Horne, R, Wolvetang, EJ and Fisk N M (2012). Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Trans Med 1: 83-95.
22. Shi, W, Wang, H, Pan, G, Geng, Y, Guo, Y and Pei, D (2006). Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J Biol Chem 281: 23319-23325.
23. LYON, MF (1961). Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190: 372-373.
24. Seki, Y, Kurisaki, A, Watanabe-Susaki, K, Nakajima, Y, Nakanishi, M, Arai, Y et al. (2010). TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. Proc Natl Acad Sci USA 107: 10926-10931.
25. Daadi, MM, Davis, AS, Arac, A, Li, Z, Maag, AL, Bhatnagar, R et al. (2010). Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 41: 516-523.
26. Yabuta, Y, Kurimoto, K, Ohinata, Y, Seki, Y and Saitou, M (2006). Gene expression dynamics during germline specifcation in mice identifed by quantitative single-cell gene expression profling. Biol Reprod 75: 705-716.
27. Surani, MA, Durcova-Hills, G, Hajkova, P, Hayashi, K and Tee, WW (2008). Germ line, stem cells, and epigenetic reprogramming. Cold Spring Harb Symp Quant Biol 73: 9-15.
28. Hayashi, K, de Sousa Lopes, SM and Surani, MA (2007). Germ cell specifcation in mice. Science 316: 394-396.
29. Moore, FL, Jaruzelska, J, Fox, MS, Urano, J, Firpo, MT, Turek, PJ et al. (2003). Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad Sci USA 100: 538-543.
30. Lee, GS, Kim, HS, Lee, SH, Kang, MS, Kim, DY, Lee, CK et al. (2005). Characterization of pig vasa homolog gene and specifc expression in germ cell lineage. Mol Reprod Dev 72: 320-328.
31. Hajkova, P, Erhardt, S, Lane, N, Haaf, T, El-Maarri, O, Reik, W et al. (2002). Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117: 15-23.
32. Nettersheim, D, Gillis, A, Biermann, K, Looijenga, LH and Schorle, H (2011). The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression. Genes Chromosomes Cancer 50: 1033-1042.
33. Graf, T and Enver, T (2009). Forcing cells to change lineages. Nature 462: 587-594.
34. Stewart, MH, Bossé, M, Chadwick, K, Menendez, P, Bendall, SC and Bhatia, M (2006). Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods 3: 807-815.
35. Maherali, N and Hochedlinger, K (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
36. Hezroni, H, Sailaja, BS and Meshorer, E (2011). Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells. J Biol Chem 286: 35977-35988.
37. Huangfu, D, Osafune, K, Maehr, R, Guo, W, Eijkelenboom, A, Chen, S et al. (2008). Induction of pluripotent stem cells from primary human fbroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
38. Lowry, WE, Richter, L, Yachechko, R, Pyle, AD, Tchieu, J, Sridharan, R et al. (2008). Generation of human induced pluripotent stem cells from dermal fbroblasts. Proc Natl Acad Sci USA 105: 2883-2888.
39. Varlakhanova, NV, Cotterman, RF, deVries, WN, Morgan, J, Donahue, LR, Murray, S et al. (2010). myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 80: 9-19.
40. Kerr, CL, Hill, CM, Blumenthal, PD and Gearhart, JD (2008). Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells 26: 412-421.
41. Zwaka, TP and Thomson, JA (2005). A germ cell origin of embryonic stem cells? Development 132: 227-233.
42. Kucia, M, Machalinski, B and Ratajczak, MZ (2006). The developmental deposition of epiblast/germ cell-line derived cells in various organs as a hypothetical explanation of stem cell plasticity? Acta Neurobiol Exp (Wars) 66: 331-341.
43. Leeman, BA and Cole, AJ (2008). Advancements in the treatment of epilepsy. Annu Rev Med 59: 503-523.
44. Taylor, CJ, Bolton, EM, Pocock, S, Sharples, LD, Pedersen, RA and Bradley, JA (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366: 2019-2025.
45. Guillot, PV, Gotherstrom, C, Chan, J, Kurata, H and Fisk, NM (2007). Human frst trimester fetal mesenchymal stem cells (MSC) express pluripotency markers, grow faster and have longer telomeres compared to adult MSC. Stem cells 25: 646-654.
46. Miller, SA, Dykes, DD and Polesky, HF (1998). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 3: 1215.
47. Cawthon, RM (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
48. Wege, H, Chui, MS, Le, HT, Tran, JM and Zern, MA (2003). SYBR Green real-time telomeric repeat amplifcation protocol for the rapid quantifcation of telomerase activity. Nucleic Acids Res 31: E3-E3.
49. Eckert, D, Nettersheim, D, Heukamp, LC, Kitazawa, S, Biermann, K and Schorle, H (2008). TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell Tissue Res 331: 529-538.